SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cell Point (India) Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

78823

INE0O0001013

39.7725521

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CELLPOINT

526.67

29.52

EPS(TTM)

Face Value()

Div & Yield %

0.03

Back

Aarey Drugs & Pharmaceuticals standalone net profit declines 25.55% in the June 2026 quarter

Aug 15,2026

Net profit of Aarey Drugs & Pharmaceuticals declined 25.55% to Rs 1.02 crore in the quarter ended June 2026 as against Rs 1.37 crore during the previous quarter ended June 2025. Sales declined 56.34% to Rs 44.63 crore in the quarter ended June 2026 as against Rs 102.21 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	44.63	102.21	-56
OPM %	2.94	1.67	-
PBDT	1.36	2.22	-39
PBT	0.51	1.73	-71
NP	1.02	1.37	-26

74,729.27 413.66 ( 0.56%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,489.63 1,063.68 (1.65%)

10,879.96 39.61 (0.37%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)